About Massive Bio
Massive Bio is a healthcare AI company focused on democratizing access to cancer clinical trials and precision medicine. The company utilizes an AI-driven platform, such as SYNERGY-AI/DLCTMS and TrialRouter AI, to match cancer patients with suitable clinical trials by analyzing their diagnosis, genomic profile, treatment history, and location against a vast database of trials. This service aims to overcome barriers like geography, financial constraints, and information asymmetry that often limit patient enrollment in crucial research. Massive Bio also provides concierge support to assist patients and physicians through the trial enrollment process, including understanding eligibility, financial aspects, and scheduling appointments.
For physicians, Massive Bio offers tools like TrialRelay™, a physician-facing operating system designed to streamline the clinical trial referral process and reduce referral friction. This platform aims to ensure that referred patients are actively carried forward in the enrollment process, addressing the issue of patients getting lost after a referral. Massive Bio’s services are designed to integrate seamlessly into clinical workflows, allowing physicians to review thousands of trials quickly, gain clear eligibility insights, and make referral decisions with greater confidence. The company collaborates with pharmaceutical companies, CROs, providers, and researchers to advance oncology drug development, commercialization, and access to precision medicine.
Focus Areas
Business Intelligence
| Technology | SYNERGY-AI/DLCTMS (Deep Learning Clinical Trial Matching System), Natural Language Processing (NLP), Computer Vision, Large Language Model (LLM) and Generative Pre-trained Text (GPT) for Dr Arturo AI (for physicians) and Ask Fiona AI (for patients), Reticulum Nexus (multi-agent platform) |
What Physicians Need to Know
Physicians can leverage Massive Bio's AI-powered platforms to proactively identify a broader range of treatment options for their cancer patients, including newly approved drugs and relevant clinical trials. The platform's ability to analyze extensive medical records, including biomarker data, and match patients with over 16,000 clinical trials instantly can significantly streamline the process of finding suitable trials. The AI-generated matches are physician-reviewed, ensuring accuracy and reliability. Additionally, the concierge support services can alleviate the administrative burden on physicians by assisting patients with eligibility, financial aspects, and appointment scheduling. The integration of Massive Bio's matching infrastructure into existing workflows, as seen in partnerships with platforms like PrecisCa, means more patients can be identified for trials without requiring separate searches. Physicians can also utilize the Massive Bio Clinical Network to review pre-screening results and oversee patient enrollment. The company's focus on real-world data and agentic AI through platforms like NexusPulse™ can provide real-time insights into biomarker testing, therapy initiation, and patient access, helping physicians make data-driven decisions.
Massive Bio's platform integrates with various entities across the healthcare ecosystem. They partner with pharmaceutical companies, contract research organizations (CROs), and hospital networks. Key integrations include collaborations with the Precision Cancer Consortium (PCC) to optimize clinical trial matching through AI analytics tools, and with Foundation Medicine to optimize clinical trial recruitment and enrollment. They also partner with FOMAT for AI-powered patient pre-screening, and with CureMatch to combine precision medicine with AI-driven clinical trial matching. Massive Bio has also expanded its network through partnerships to enhance access to oncology clinical trials in Latin America. Their technology stack includes Python 3.12 and they have experience with CRM integrations like HubSpot and Salesforce. The company's platform ecosystem includes Reticulum Nexus™, SYNERGY-AI™, TrialRelay™, Radiant Core™, and NexusPulse™, which connect patients, providers, sites, and life sciences organizations.
What the Web Says
Massive Bio is a digital health company that utilizes AI and physician expertise to connect cancer patients with suitable clinical trials globally. They aim to provide equal access to cutting-edge therapies and clinical trials, offering services like AI-driven trial matching, virtual tumor boards, and concierge support. The company has received mixed reviews, with many patients praising their services and support, while some express concerns about communication and employer practices.
Overall: MixedStrengths
- AI-driven clinical trial matching identifies trials that other methods miss, including basket and platform trials.
- Provides personalized reports outlining suitable trials within 24 hours.
- Offers direct connection to compassionate and knowledgeable oncology nurse navigators for free.
- Provides ongoing concierge support, assisting with eligibility, financial aspects, and appointment scheduling.
- Offers virtual tumor boards with expert opinions from specialists at major cancer research centers.
- Helps patients access advanced testing like Foundation One and NGS testing.
Limitations
- Some users report difficulties in contacting the team and a lack of timely communication.
- Employer reviews mention a lack of transparency, leadership, and support from executive management.
- Some employees report being belittled, gossiped about, and having no opportunities for growth.
- A few users on Reddit found the service unhelpful or that it didn't provide new information beyond their own research.
- One doctor described them as 'terrible and unorganized'.
- Concerns about the legitimacy of some Reddit posts related to the company's AMA.
Based on reviews from: Asklepieia Health, OncoDaily, Cancer2ndOpinion, Clinical Trials Arena, Reddit, Indeed, Built In NYC, Built In
Last updated: 2026-10-30
Videos
News, demos, and interviews about Massive Bio.
Videos load interactively. If none appear, search YouTube for Massive Bio →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Massive Bio.
Related Companies
Steer Health is an AI-powered growth and automation platform designed to optimize patient experiences and enhance revenue for healthcare organizations. The company’s platform utilizes artificial intelligence to automate various administrative tasks, including eligibility checks, referrals, payments, and patient intake. This automation facilitates personalized online scheduling, appointment reminders, and patient communication services, ultimately aiming to improve […]
Xealth is a healthcare AI company that provides a care orchestration platform designed to seamlessly integrate digital health tools and programs into existing clinical workflows. For physicians, this means the ability to prescribe and monitor digital health content, applications, and services directly from within their Electronic Health Record (EHR) system, much like ordering traditional medications. […]
EXF Health, a vertical of Exafluence, focuses on enhancing healthcare organizations by strengthening their health IT infrastructure and improving their analytics and data maturity. The company leverages best-in-class AI/ML tools and techniques to add continuous value to all healthcare participants. For healthcare payers, EXF Health offers executive decision boards that provide actionable insights to track […]
Epic Systems is a privately held healthcare software company that develops and offers a comprehensive suite of products designed to improve patient care and operational efficiency across various healthcare settings. Their software serves as a central nervous system for hospitals and health clinics, integrating nearly every aspect of patient care, from appointment scheduling and clinical […]
AppCatalyst is a healthcare mobile app development company that specializes in “Digital Front Door” solutions. Their primary goal is to empower consumers throughout critical moments in their healthcare journey. The company’s origins trace back to 2009, when they converted a highly-rated website symptom checker into a mobile application. This symptom checker, along with other content, […]
Syntra AI is a healthcare artificial intelligence company focused on streamlining and accelerating healthcare payments and administrative tasks. Their flagship product, Syntra Autonomous, automates pre-bill chart review, claim review, and submission. This system is designed to help medical practices identify missed revenue or compliance issues and improve billing accuracy and financial outcomes by applying AI-powered […]